Cargando…

Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy

By performing regular blood transfusion and iron chelation therapy, most patients with beta thalassemia major (BTM) now survive beyond the third decade of life. Liver disease is becoming an important cause of morbidity and mortality in these patients. Chronic hepatitis and/or severe iron overload ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soliman, Ashraf, Yassin, Mohamed, Al Yafei, Fawzia, Al-Naimi, Lolwa, Almarri, Noora, Sabt, Aml, De Sanctis, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010606/ https://www.ncbi.nlm.nih.gov/pubmed/24803998 http://dx.doi.org/10.4084/MJHID.2014.025

Ejemplares similares

Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Cortisol response to low dose versus standard dose (back-to-back) adrenocorticotrophic stimulation tests in children and young adults with thalassemia major
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Vitamin D Status in Thalassemia Major: an Update
por: Soliman, Ashraf, et al.
Publicado: (2013)

Postnatal growth of infants with neonatal diabetes: Insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy
por: Alyafie, Fawzia, et al.
Publicado: (2019)

Insulin-like growth factor- I and factors affecting it in thalassemia major
por: Soliman, Ashraf T., et al.
Publicado: (2015)

Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar
por: Alyafei, Fawzia, et al.
Publicado: (2018)

Incidence of type 1 and type 2 diabetes, between 2012-2016, among children and adolescents in Qatar
por: Alyafei, Fawzia, et al.
Publicado: (2018)

Clinical and biochemical characteristics of familial type 1 diabetes mellitus (FT1DM) compared to non-familial type 1 DM (NFT1DM)
por: Alyafei, Fawzia, et al.
Publicado: (2018)

A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation
por: Ahmed, Shayma, et al.
Publicado: (2022)

Nutritional studies in patients with β-thalassemia major: A short review
por: Soliman, Ashraf, et al.
Publicado: (2023)

PB2540: HEPATIC SAFETY PROFILE OF DEFERASIROX IN CHILDREN WITH BETA THALASSEMIA MAJOR IN OMAN
por: Almadhani, Shaimaa, et al.
Publicado: (2023)

Deferasirox in Indian children with thalassemia major: 3 years experience
por: Dhamija, Mayank, et al.
Publicado: (2013)

Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018)

Growth hormone – insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major
por: Soliman, Ashraf, et al.
Publicado: (2014)

Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia
por: Hagag, Adel A., et al.
Publicado: (2013)

Myxedema coma in children and adolescents: A rare endocrine emergency - Personal experience and review of literature
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Does priming with sex steroids improve the diagnosis of normal growth hormone secretion in short children?
por: Soliman, Ashraf, et al.
Publicado: (2014)

A DFX-based iron nanochelator for cancer therapy
por: Liu, Peng, et al.
Publicado: (2022)

Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC
por: Soliman, Ashraf T, et al.
Publicado: (2018)

Deferasirox: Over a Decade of Experience in Thalassemia
por: Moukalled, Nour M., et al.
Publicado: (2018)

The effects of excess weight on glucose homeostasis in young adult females with β-thalassemia major (β-TM): A preliminary retrospective study
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Current practice in treating adult female thalassemia major patients with hypogonadism: An International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine survey from Italy
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Late-onset Male Hypogonadism and Fertility Potential in Thalassemia Major Patients: Two Emerging Issues
por: De Sanctis, Vincenzo, et al.
Publicado: (2015)

Spinal cord compression secondary to extramedullary hematopoiesis: a rareness in a young adult with thalassemia major
por: Fareed, Shehab, et al.
Publicado: (2017)

Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis
por: Yassin, Mohamed A., et al.
Publicado: (2014)

Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Evolution of combined impaired fasting glucose and impaired glucose tolerance in β-thalassemia major: Results in 58 patients with a mean 7.7- year follow-up
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Insulin-like growth factor -1 (IGF-1) and glucose dysregulation in young adult patients with β-thalassemia major: causality or potential link?
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications
por: Kanbour, Ibrahim, et al.
Publicado: (2018)

Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major
por: Pathare, Anil, et al.
Publicado: (2009)

Quality of life among adolescents aged 14 to 18 years with beta-thalassemia major (TM) in Qatar
por: Nashwan, Abdulqadir J., et al.
Publicado: (2018)

The recommendation of the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine for the assessment of growth hormone secretion in thalassemia
por: De Sanctis, Vincenzo, et al.
Publicado: (2015)

Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content
por: Yassin, Mohamed A., et al.
Publicado: (2019)

Delafloxacin-Capped Gold Nanoparticles (DFX-AuNPs): An Effective Antibacterial Nano-Formulation of Fluoroquinolone Antibiotic
por: Abu Lila, Amr Selim, et al.
Publicado: (2022)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes
por: Ricchi, Paolo, et al.
Publicado: (2015)

Comparison of contrast sensitivity in β-thalassemia patients treated by deferoxamine or deferasirox
por: Ghazanfari, Azam, et al.
Publicado: (2019)

Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent β-thalassemia
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2017)

Spontaneous iliopsoas hematoma in a trasfusion dependent β-thalassemia patient with hypersplenism: a case report
por: Aishwariya, Padmakumari, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_leuu04kqhif3269e0v5kd0rtpg